Interrelationship of apoptosis, mutation, and cell proliferation in N-methyl-N'-nitro-N-nitrosoguanidine

Kwak1, Lee, Cho

  • 1Laboratory of Toxicology, College of Veterinary Medicine, Seoul National University, 441-744, Suwon, Korea

Insights

This study shows N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) exposure in medaka fish leads to glutathione (GSH) depletion, apoptosis, and mutations. Medaka fish are a suitable model for studying carcinogenesis progression.

Area of Science:

  • Environmental toxicology
  • Molecular biology
  • Carcinogenesis research

Background:

  • Carcinogen exposure can induce complex cellular responses including DNA damage, altered cell proliferation, and cell death.
  • Understanding the sequential events in carcinogenesis is crucial for developing effective prevention and treatment strategies.
  • Medaka fish (Oryzias latipes) are a valuable model organism for aquatic toxicology and cancer research due to their sensitivity and genetic tractability.

Purpose of the Study:

  • To investigate the interrelationship between glutathione (GSH) depletion, apoptosis, mutation, and cell proliferation following exposure to N-methyl-N itro-N-nitrosoguanidine (MNNG) in medaka fish.
  • To evaluate the medaka fish as a model organism for studying the progression of carcinogenesis.

Main Methods:

  • Medaka fish were exposed to MNNG at varying concentrations (0, 0.5, 1 mg l(-1)) for 28 days.
  • GSH levels were measured, and apoptotic/necrotic changes were assessed using flow cytometry at 3, 5, and 7 months post-exposure.
  • Mutational analysis was performed using arbitrarily primed polymerase chain reaction (AP-PCR) fingerprinting.
  • Tumor development was assessed through histological examination and immunohistochemistry for proliferating cell nuclear antigen (PCNA).

Main Results:

  • MNNG exposure led to decreased GSH levels in a dose- and time-dependent manner.
  • Apoptotic changes were observed in a dose- and time-dependent manner at 3 and 5 months, with increased necrosis and carcinogenic alterations at 7 months.
  • Time-dependent mutations were detected, but no clear concentration-dependent mutational response was observed.
  • Spindle cell sarcomas were identified in some fish, with actively proliferating tumor cells, alongside ongoing apoptosis in non-tumored tissues.

Conclusions:

  • The study elucidates the interconnectedness of GSH depletion, apoptosis, mutation, and cell proliferation in the context of MNNG-induced carcinogenesis.
  • Medaka fish demonstrate a robust response to MNNG, supporting their utility as a model for investigating the stages of carcinogenesis.
  • The findings highlight the dynamic interplay of cellular events during cancer development, from initial damage to tumor formation and cell death.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...